ARAnnamarija Raic

Annamarija Raic

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Annamarija Raic has a total of 7 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Time-Resolved Profiling: Metabolic Adaptation & Morphology-Specific Drug Response in MCF-7 spheroids

    by Annamarija Raic, Marcel Utz, Sylwia Barker, Nora Schäfer, Yaping Li

    Three-dimensional (3D) tumor models exhibit drug responses that differ from conventional 2D cultures. However, how cellular metabolism dynamically evolves across culture models and during drug treatment remains poorly understood. We compared the responses of MCF-7 cells in 2D and 3D environments to 5-fluorouracil (5-FU), combining 1 H NMR cellular metabolomics with viable cell counts, the GLUT1-positive population, gene expression, ATP activity, and morphology. Principal component analysis revealed that culture dimensionality, rather than 5-FU treatment, was the primary driver of metabolic flux variation. 3D spheroids exhibited higher glycolytic flux at 72h. Importantly, this elevated glycolysis reflected a higher per-cell flux in larger spheroids rather than an increased cell number. We further observed a higher proportion of GLUT1-positive cells and increased HK2 expression in 3D culture, together with an epithelial phenotype characterized by increased CDH1 and decreased VIM expression. Functionally, 3D displayed maintaining higher cell viability, ATP activity following treatment. Together, these findings suggest that 3D architecture promotes a metabolically defensive phenotype and cellular metabolic behaviors is associated with morphology, which may inform future drug screening model selection.


  • Open Access

    Stage-resolved iPSC-to-motoneuron differentiation: Metabolic switch & mitochondrial remodeling

    by John Jbeily, Annamarija Raic, Mathias Hafner, Rudiger Rudolf

    Development of motoneurons from stem cells is characterized by a change from glycolytic to oxidative metabolism. Since this transition remains poorly understood, we examined it at five distinct differentiation stages from hiPSC to motoneuron. While a direct comparison of hiPSCs and mature motoneurons confirmed the expected glycolytic-to-oxidative shift, the intermediate stages showed that the conversion was not monotonic. After an initial drop of glycolysis at the hiPSC-to-neuroepithelial transition, late neuroepithelial cells showed intermittent peaks of the glycolytic marker lactate dehydrogenase A and the metabolic regulator TIGAR. Furthermore, the lactate-produced-to-glucose-consumed ratio remained elevated. A fully oxidative phenotype was only assumed upon progress from neural progenitors to motoneurons, portrayed by a definitive drop of the lactate-produced-to-glucose-consumed ratio, an increase of mitochondrial membrane charging, and shifts from lactate dehydrogenase A to B, from pyruvate dehydrogenase to anaplerotic pyruvate carboxylase, and from Mitofusin 1 to 2. Together, our data show that metabolic maturation in human motoneurons does not occur as a simple switch. Instead, it unfolds through distinct stages in a directional yet nonlinear manner.